Apple extract can promote stem cell regeneration and help maintain homeostasis
In this study published in the journal Nutrition Research, researchers from Sungkyunkwan University in South Korea investigated the proliferative effect of apple ethanol extract on human adipose tissue-derived mesenchymal stem cells (ADSCs) and human cord blood-derived mesenchymal stem cells (CB-MSCs). They also identified the possible molecular mechanisms behind its beneficial effects. Tissue regeneration using... (Source: NaturalNews.com)
Source: NaturalNews.com - May 23, 2019 Category: Consumer Health News Source Type: news

Studying the function of liver cancer genes in mini-organs
(Hubrecht Institute) Researchers from the Hubrecht Institute developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in liver cancer. Using this method, they have found that mutations in BAP1, a gene commonly mutated in liver cancer, changes the behavior of the cells, which may make them more likely to be invasive. Their results were published in Cell Stem Cell. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 23, 2019 Category: Cancer & Oncology Source Type: news

Experimental noninvasive tool monitors effectiveness of stem cell transplantation
(University of Maryland Medical Center) Other than clinical observations, the stem cell field lacks a repeatable, time-sensitive, noninvasive tool to assess the effectiveness of transplanted cells in the targeted organ. Researchers analyzed biomarkers secreted from transplanted human stem cells in the recipient blood of a rodent model of heart attack. Analysis of the blood test showed responding cells had changed their gene expression, behavior and secretions, suggesting this liquid biopsy could provide a window into stem cell activity and effectiveness. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 22, 2019 Category: Biology Source Type: news

Allen Institute for Cell Science debuts first comprehensive view of human cell division
(Allen Institute) The Allen Institute today released the Integrated Mitotic Stem Cell, a data-driven model and visualization tool that captures -- for the first time -- a holistic view of human cell division. By enabling a deeper understanding of how healthy human cells divide, a process known as mitosis, the model will further basic biology research as well as studies of cancer, a disease that often results from cell division gone awry. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2019 Category: International Medicine & Public Health Source Type: news

Stem cell differences could explain why women are more likely to develop adrenal cancer
(Worldwide Cancer Research) Scientists have discovered a potential biological reason why women are more likely to develop adrenal disorders, including cancer. According to the researchers, the answer could lie in the increased turnover of hormone-producing cells found in the adrenal glands of females. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 21, 2019 Category: Cancer & Oncology Source Type: news

Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of...
On May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex received unanimous approval of its proposal for an...(PRWeb May 21, 2019)Read the full story at https://www.prweb.com/releases/asymmetrex_approved_to_conduct_an_astm_interlaboratory_evaluation_of_its_alphastem_test_technology_as_a_standard_for_counting_therapeutic_adult_tissue_stem_cells/prweb16325709.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 21, 2019 Category: Pharmaceuticals Source Type: news

Zebrafish help researchers explore alternatives to bone marrow donation
(University of California - San Diego) UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2019 Category: International Medicine & Public Health Source Type: news

'Stem cell' therapies offered at private clinics need to be approved as drugs, Health Canada says
Across Canada, private clinics charge thousands of dollars for injections and IV therapies using what they claim are stem cells. This week, Health Canada ruled that those cell therapies are drugs that must be approved. But so far, the agency has not ordered clinics to stop doing the procedures. (Source: CBC | Health)
Source: CBC | Health - May 18, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Sharp rise in number of parents forking out thousands to freeze baby's umbilical cord
Some 27,028 Britons had stem-cell-rich umbilical-cord blood stored in special ‘bio-banks' in 2018 compared with 16,965 in 2014. The hope is that they'll one day cure a host of medical conditions. (Source: the Mail online | Health)
Source: the Mail online | Health - May 16, 2019 Category: Consumer Health News Source Type: news

Ford government scraps funding for stem cell research
The Ford government plans to stop all provincial funding to an institute that supports Ontario scientists at the cutting edge of stem cell research. (Source: CBC | Health)
Source: CBC | Health - May 16, 2019 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

What do they mean by 'stem cells'? Recommended guidelines for reporting on cell therapies
(Wolters Kluwer Health) Cell therapies including so-called 'stem cells' are increasingly being marketed and used for the treatment of musculoskeletal disorders -- despite questions about these treatments and their effectiveness. A new tool for standardizing communication about cell therapies is presented in the May 15, 2019 issue of The Journal of Bone& Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2019 Category: International Medicine & Public Health Source Type: news

Surprising research result: All immature cells can develop into stem cells
(University of Copenhagen The Faculty of Health and Medical Sciences) New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development. The study reveals that the destiny of intestinal cells is not predetermined, but instead determined by the cells' surroundings. The new knowledge may make it easier to manipulate stem cells for stem cell therapy. The results have just been published in Nature. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2019 Category: International Medicine & Public Health Source Type: news

Cancer drugs promote stem cell properties of colorectal cancer
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells. This can lead to the accumulation of tumor cells with stem cell characteristics that are resistant to many therapies and can lead to relapses. The researchers thus provide a possible explanation for why these drugs are not effective in colorectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Cord blood: Rise in parents paying for private banking
Frozen stem cells from umbilical cord blood and tissue can be used if babies get ill in the future. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 16, 2019 Category: Consumer Health News Source Type: news

Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of...
Today, March 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex will present a proposal for an interlaboratory evaluation...(PRWeb May 16, 2019)Read the full story at https://www.prweb.com/releases/asymmetrex_presents_proposal_for_astm_interlaboratory_evaluation_of_alphastem_test_technology_towards_establishing_a_standard_for_counting_therapeutic_stem_cells/prweb16316460.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2019 Category: Pharmaceuticals Source Type: news

Cardiac Stem Cells in the Post-Anversa Era Cardiac Stem Cells in the Post-Anversa Era
Recent investigations have discredited much of the literature supporting c-Kit+ cardiac stem cells having any role in cardiac repair. Where do we go from here?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 15, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

A nerve cell serves as a 'single' for studies
(University of Bonn) Nerve cells derived from human stem cells often serve as the basis for research into brain diseases. However, these cells differ considerably in their quality and produce varying results. Scientists are therefore looking for simple cell models that lead to consistent results. Research teams from the University of Bonn, the Vrije Universiteit Amsterdam and the Max Planck Institute for Experimental Medicine in G ö ttingen describe a model that consists of only one human nerve cell. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2019 Category: International Medicine & Public Health Source Type: news

MDI biological laboratory receives $30,000 to support organoid course
(Mount Desert Island Biological Laboratory) The MDI Biological Laboratory has announced that it has received more than $30,000 in cash and in-kind awards in support of its second annual 'Applications of Organoid Technology' course, to be held May 26 through June 1, 2019 at the institution's Bar Harbor, Maine, campus. The week-long course is among the first to provide extensive hands-on training in methods to grow the stem cell-derived three dimensional mini-organs from patient tissues. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2019 Category: International Medicine & Public Health Source Type: news

Immune system discovery could aid quest for stem cell therapies
(University of Edinburgh) Scientists have discovered how stem cells can develop resistance against viruses, a finding that could aid the development of stem cell therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2019 Category: International Medicine & Public Health Source Type: news

Stem Cell Treatments Flourish With Little Evidence That They Work
The F.D.A. has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints. (Source: NYT Health)
Source: NYT Health - May 13, 2019 Category: Consumer Health News Authors: DENISE GRADY and REED ABELSON Tags: Stem Cells Knees Hips Health Insurance and Managed Care Bone Marrow Regulation and Deregulation of Industry Centers for Disease Control and Prevention Regenexx Food and Drug Administration your-feed-healthcare Source Type: news

Turning off growth to make flowers grow
(Nara Institute of Science and Technology) Researchers at the Nara Institute of Science and Technology (NAIST) report the final epigenetic events that terminate stem cell growth for proper flower development. They show the series of steps the binding of the transcription factor KNUCKLES initiates to suppress the gene expression of WUSCHEL in Arabidopsis. The ability to control flower growth has implications on seed productivity and food technology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 13, 2019 Category: Biology Source Type: news

Dr. David Greene and R3 Stem Cell Achieve IRB Approval for...
Dr. David Greene and R3 Stem Cell have achieved IRB Approval for regenerative therapies. The approval is the only one of its kind in the United States and practices nationwide may participate with R3.(PRWeb May 12, 2019)Read the full story at https://www.prweb.com/releases/dr_david_greene_and_r3_stem_cell_achieve_irb_approval_for_regenerative_therapies/prweb16305683.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 12, 2019 Category: Pharmaceuticals Source Type: news

Nigeria: Nigerian-German Mother Seeks Life-Saving Stem Cell Transplant Donor
[Premium Times] A Nigerian-German mother of two is hoping for a miracle as she searches for a stem cell donor so that she can live to see her sons grow. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 10, 2019 Category: African Health Source Type: news

Prince Charming's kiss unlocking brain's regenerative potential?
(Kyoto University) Kyoto University researchers find that 'waves' of Hes1 and Ascl1 gene expression control the quiescent and active state of adult neural stem cells. Hes1 expression promotes quiescence and suppresses Ascl1, and knocking out Hes1 increases Ascl1 expression and subsequent adult neural stem cell activation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2019 Category: International Medicine & Public Health Source Type: news

Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications - Venkatesh K, Ghosh SK, Mullick M, Manivasagam G, Sen D.
Axonal regeneration and formation of tripartite (axo-glial) junctions at damaged sites is a prerequisite for early repair of injured spinal cord. Transplantation of stem cells at such sites of damage which can generate both neuronal and glial population ha... (Source: SafetyLit)
Source: SafetyLit - May 10, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Vital work of specialist nurses praised by transplant patient
A patient who underwent a stem cell transplant has praised the “incredible” efforts of his specialist nurse – a person he said he “would not have got to this point” in his recovery without. (Source: Nursing Times)
Source: Nursing Times - May 9, 2019 Category: Nursing Source Type: news

Stem cells may be useful in treating diabetes
Stem cells can be used to deriveβ-cells to be transplanted into patients with diabetes, according to research published inNature.Nature (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 9, 2019 Category: Endocrinology Source Type: news

Will MSC micropellets outperform single cells for cartilage regeneration?
(Mary Ann Liebert, Inc./Genetic Engineering News) Repair of cartilage injuries or defects is aided by the introduction of mesenchymal stem cells (MSCs), which can be incorporated into hydrogels to amplify their effects. In a new report, researchers directly compared chondrogenic induction by hydrogels that were prepared using MSCs either as single cell suspensions or as 100-500-cell micropellets. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 9, 2019 Category: Biology Source Type: news

Personalized 'Eye-in-a-Dish' models reveal genetic underpinnings of macular degeneration
(University of California - San Diego) Using stem cells derived from six people, UC San Diego School of Medicine researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants that cause age-related macular degeneration, a common cause of vision loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

ReNeuron Provides Business Update and Results Notification
Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete LONDON, May 8, 2019 -- (Healthcare Sales & Marketing Network) -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, announced a year-end... Regenerative Medicine, Ophthalmology, Neurology ReNeuron Group, retinitis pigmentosa, stroke, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2019 Category: Pharmaceuticals Source Type: news

Clinical Trial Underway for a Natural Killer Cell Therapy
The cells, derived from induced pluripotent stem cells, are in testing as an immunotherapy for cancer patients with solid tumors. (Source: The Scientist)
Source: The Scientist - May 7, 2019 Category: Science Tags: News & Opinion Source Type: news

New AlphaGRAFT DBM Fiber Technology Improves Regenerative Capacity
Optimized handling enables combination with allograft or autograft for use in spinal fusion procedures Provides moldable allograft with cohesive handling characteristics and osteoconductive scaffold for delivery of autologous stem cells Regenerative capacity exhibits all five elements of new bone formation in validated animal modelsThis story is related to the following:Surgical Implants (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - May 7, 2019 Category: Medical Devices Source Type: news

UW-Madison research team finds new ways to generate stem cells more efficiently
(University of Wisconsin-Madison) A new study published in Cell Reports by a team of researchers at the University of Wisconsin-Madison's Wisconsin Institute for Discovery and School of Medicine and Public Health could improve the efficiency of creating induced pluripont stem cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 7, 2019 Category: Biology Source Type: news

Stem cells make more 'cargo' packets to carry cellular aging therapies
(Johns Hopkins Medicine) Johns Hopkins scientists report that adult cells reprogrammed to become primitive stem cells, called induced pluripotent stem cells (iPSCs), make tiny 'cargo packets' able to deliver potentially restorative or repairing proteins, antibodies or other therapies to aged cells. They say the human iPSCs they studied produced much more of the packets, formally known as extracellular vesicles, than other kinds of adult stem cells commonly used for this purpose in research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2019 Category: International Medicine & Public Health Source Type: news

Pigment-producing stem cells can regenerate vital part of nervous system
(University of Maryland School of Medicine) Neurodegenerative diseases like multiple sclerosis (MS) affect millions of people worldwide and occur when parts of the nervous system lose function over time. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered that a type of skin-related stem cell could be used to help regenerate myelin sheaths, a vital part of the nervous system linked to neurodegenerative disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 6, 2019 Category: International Medicine & Public Health Source Type: news

The immaculate conception?
(The Hebrew University of Jerusalem) A new, groundbreaking study by the Hebrew University of Jerusalem (HU) found a way to transform skin cells into the three major stem cell types that comprise early-stage embryos. This work has significant implications for modelling embryonic disease and placental dysfunctions, as well as paving the way to create whole embryos from skin cells. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 2, 2019 Category: International Medicine & Public Health Source Type: news

Pluripotency or differentiation -- That is the question
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Induced pluripotent stem cells can turn into any type of cell in the body or remain in their original form. In Molecular Cell, scientists from the Helmholtz Zentrum M ü nchen describe how cells 'decide' which of these two directions to take. During their research, they identified a protein and a ribonucleic acid (RNA) that play a highly significant role in this process. Their discovery also allows a better understanding of amyotrophic lateral sclerosis (ALS)*. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2019 Category: International Medicine & Public Health Source Type: news

Stem cell therapies and regenerative medicine moving toward the clinic
(International Society for Stem Cell Research) Stem cell research is leading to potential new therapies to treat disease, with several applications in clinical trials or expected to enter trials in the coming months. These new discoveries will be key to discussions at the International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center. More than 4,000 scientists, bioethicists, clinicians, industry professionals, and others from over 50 countries will present in more than 200 talks and 27 cutting-edge sessions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2019 Category: International Medicine & Public Health Source Type: news

Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year. (Source: The Scientist)
Source: The Scientist - April 30, 2019 Category: Science Tags: News & Opinion Source Type: news

$4.6 million grant funds clinical trial of stem cell immunotherapy for metastatic sarcoma and other hard-to-treat cancers
(University of California - Los Angeles Health Sciences) Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have been awarded a $4.6 million grant from the California Institute for Regenerative Medicine -- also known as CIRM -- to support a phase I clinical trial of a novel treatment for advanced sarcomas and other cancers with a specific tumor marker called NY-ESO-1. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 29, 2019 Category: Cancer & Oncology Source Type: news

We Have Human Bone Marrow Derived Stem Cells
Pure and Potent-Only $655/500,000 CellsHuman Mesenchymal Stem Cells isolated from bone marrow and provided a low passage. These cells have the ability to be passaged five to 10 passages in our Low Serum, Complete Medium (#SC00B1); which is optimized for high growth rates, reduced doubling times, healthy cells and stability. This Product is manufactured, tested and validated in an ISO 9001/ISO13485/CLIA certified facility. (Source: Neuromics)
Source: Neuromics - April 27, 2019 Category: Neuroscience Tags: human Mesenchymal Stem Cell Based Assays Human Mesenchymal Stem Cells Source Type: news

Because it works so well, adult stem cell therapy is now being targeted by the FDA for elimination
(Natural News) The U.S. Food and Drug Administration is on a mission to eliminate all access to adult stem cell therapy, a medical protocol that involves utilizing a patient’s own endogenous stem cells for regenerative healing. And putting two and two together, it’s because this natural technique doesn’t require the use of any pharmaceutical drugs,... (Source: NaturalNews.com)
Source: NaturalNews.com - April 26, 2019 Category: Consumer Health News Source Type: news

Image of the Day: Powerful Protein
An experiment tests whether a protein treatment can help hematopoietic stem cells recover after mice are exposed to radiation. (Source: The Scientist)
Source: The Scientist - April 25, 2019 Category: Science Tags: Image of the Day Source Type: news

Cell competition during reprogramming gives rise to dominant clones
The ability to generate induced pluripotent stem cells from differentiated cell types has enabled researchers to engineer cell states. Although studies have identified molecular networks that reprogram cells to pluripotency, the cellular dynamics of these processes remain poorly understood. Here, by combining cellular barcoding, mathematical modeling, and lineage tracing approaches, we demonstrate that reprogramming dynamics in heterogeneous populations are driven by dominant "elite" clones. Clones arise a priori from a population of poised mouse embryonic fibroblasts derived from Wnt1-expressing cells that may r...
Source: ScienceNOW - April 25, 2019 Category: Science Authors: Shakiba, N., Fahmy, A., Jayakumaran, G., McGibbon, S., David, L., Trcka, D., Elbaz, J., Puri, M. C., Nagy, A., van der Kooy, D., Goyal, S., Wrana, J. L., Zandstra, P. W. Tags: Cell Biology, Development, Online Only r-articles Source Type: news

Domination in the stem cell world
(Source: ScienceNOW)
Source: ScienceNOW - April 25, 2019 Category: Science Authors: Purnell, B. A. Tags: Cell Biology, Development twis Source Type: news

Stem Cell Transplant An Effective Tool in Autoimmune Disease Stem Cell Transplant An Effective Tool in Autoimmune Disease
Patients with severe and refractory autoimmune disease such as multiple sclerosis can have marked improvements with hematopoietic stem cell transplant, as long as they are well selected, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 23, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Welding with stem cells for next-generation surgical glues
Scientists at the University of Bristol have invented a new technology that could lead to the development of a new generation of smart surgical glues and dressings for chronic wounds. The new method, pioneered by Dr Adam Perriman and colleagues, involves re-engineering the membranes of stem cells to effectively “ weld ” the cells together. (Source: University of Bristol news)
Source: University of Bristol news - April 23, 2019 Category: Universities & Medical Training Tags: Health, Research; Institutes, Bristol BioDesign Institute, Faculty of Life Sciences, Faculty of Life Sciences, School of Cellular and Molecular Medicine; Press Release Source Type: news

Medical News Today: Using stem cells to combat osteoarthritis
Osteoarthritis is a common condition without a cure. A recent small-scale pilot study concludes that stem cell therapies could offer some hope. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 23, 2019 Category: Consumer Health News Tags: Osteoarthritis Source Type: news

FEFU scientists are developing brand-new method to heal brain cancer
(Far Eastern Federal University) Scientists from Far Eastern Federal University (FEFU) in cooperation with colleagues from Blokhin Russian Cancer Research Center (Moscow), Switzerland, and Sweden for the first time studied proteins, which constitute WNT signaling pathway of the cancer stem cells of glioblastoma multiforme (GBM CD133+ CSCs), one of the most aggressive brain tumors. Researchers revealed a number of proteins, which are potential targets to attack during complex antitumor therapy. A related article was published in Oncology Reports. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 22, 2019 Category: Biology Source Type: news

Stem cells reduce pain of knee arthritis: Mayo Clinic Radio Health Minute
Many people suffer from painful and debilitating osteoarthritis of the knee. In a recent study, experts at Mayo Clinic tested?the benefit of using bone marrow stem cells to reduce arthritic pain and disability.? In this Mayo Clinic Radio Health Minute, Dr. Shane Shapiro?talks about how stem cell therapy offers great hope for the future of [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 22, 2019 Category: Databases & Libraries Source Type: news